Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9693 |
High Similarity |
NPD7074 |
Phase 3 |
0.9573 |
High Similarity |
NPD7472 |
Approved |
0.9512 |
High Similarity |
NPD7054 |
Approved |
0.9341 |
High Similarity |
NPD7251 |
Discontinued |
0.9286 |
High Similarity |
NPD7808 |
Phase 3 |
0.9281 |
High Similarity |
NPD6797 |
Phase 2 |
0.9172 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.9102 |
High Similarity |
NPD3818 |
Discontinued |
0.8982 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8982 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8982 |
High Similarity |
NPD6166 |
Phase 2 |
0.8848 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8834 |
High Similarity |
NPD1934 |
Approved |
0.8824 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.878 |
High Similarity |
NPD2801 |
Approved |
0.8667 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8412 |
Intermediate Similarity |
NPD5494 |
Approved |
0.84 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8284 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8263 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8249 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8232 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8187 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8142 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8133 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8125 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8118 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8079 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.807 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8056 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8056 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8046 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8033 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7966 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7953 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7898 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7845 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7821 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7795 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7772 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7749 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7749 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7747 |
Intermediate Similarity |
NPD7240 |
Approved |
0.774 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.772 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.772 |
Intermediate Similarity |
NPD7697 |
Approved |
0.772 |
Intermediate Similarity |
NPD7698 |
Approved |
0.772 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7661 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7653 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7651 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD37 |
Approved |
0.7636 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7611 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7577 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7556 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7552 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7544 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7542 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7529 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7513 |
Intermediate Similarity |
NPD7584 |
Approved |
0.75 |
Intermediate Similarity |
NPD1240 |
Approved |
0.75 |
Intermediate Similarity |
NPD943 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7487 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7459 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7423 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7416 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7381 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7349 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7333 |
Intermediate Similarity |
NPD919 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7323 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7323 |
Intermediate Similarity |
NPD8319 |
Approved |
0.731 |
Intermediate Similarity |
NPD3750 |
Approved |
0.731 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7301 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7254 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7254 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7251 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7246 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7241 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7204 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7175 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD920 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7129 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7129 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7128 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7079 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7079 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7045 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD3748 |
Approved |
0.6989 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6988 |
Remote Similarity |
NPD9494 |
Approved |
0.6981 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6978 |
Remote Similarity |
NPD5353 |
Approved |
0.6963 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6963 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6949 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6946 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6946 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6936 |
Remote Similarity |
NPD2344 |
Approved |
0.6933 |
Remote Similarity |
NPD1091 |
Approved |
0.6919 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6919 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6914 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6898 |
Remote Similarity |
NPD5242 |
Approved |
0.6891 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6881 |
Remote Similarity |
NPD5006 |
Approved |
0.6881 |
Remote Similarity |
NPD5005 |
Approved |
0.6875 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6872 |
Remote Similarity |
NPD6842 |
Approved |
0.6872 |
Remote Similarity |
NPD6841 |
Approved |
0.6872 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6864 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6864 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6857 |
Remote Similarity |
NPD1243 |
Approved |
0.6854 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD5710 |
Approved |
0.6845 |
Remote Similarity |
NPD5711 |
Approved |
0.6842 |
Remote Similarity |
NPD7930 |
Approved |
0.6836 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD2798 |
Approved |
0.6824 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD6386 |
Approved |
0.6813 |
Remote Similarity |
NPD6385 |
Approved |
0.6796 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6786
|
Remote Similarity |
NPD2861 |
Phase 2 |